Having to obtain informed consent for the use of left-over human tissue samples could be hampering essential biobank research says a research group on bmj.com today.
Joanna Stjernschantz Forsberg and colleagues at Uppsala University in Sweden, argue that the requirement for informed consent for biobank research is problematic for two main reasons. First, it consumes resources that could be directed towards more research or healthcare, and second, it imposes a risk of selection bias.